Global Head, Real-World & Late Phase Research, Quintiles
Andrea Spannheimer is global head of Real-World & Late Phase Research at Quintiles, a position she was appointed to in 2015. In this role, Andrea leads the company’s real-world and late phase research operations and strategy.
Bringing more than 20 years of experience to Quintiles, Andrea previously served as group president for Global Real-World Evidence, Late Phase Research and Health Economics at Optum Lifescience. She was responsible for the successful execution of all late phase programs and provided chief operational support and strategy for business development in this area. Andrea has also held leadership positions at i3 Innovus and Kendle International.
Andrea is a member of several professional associations including the International Society of Pharmacoeconomics & Outcomes Research and the German Association of Health Economics.
Andrea holds a Master of Science in Biology from Friedrich Alexander University of Erlangen.